Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a Beta-Blocker

Cardiology (Switzerland)

Volumn 87, Issue 5, 1996, Pages 409-414

  Rosenthal, J ^a   Bahrmann, H ^b   Benkerth, K ^b   Baumgart, P ^c   Bonner G ^d   Klein, G ^e   Neiss, A ^e   Schnelle, K ^e   Frohlich, E D ^f  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Gödccke Parke Davis   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f OCHSNER MEDICAL CENTER   (United States)

Author keywords

ACE inhibitor; Adverse events; Antihypertensive therapy; Drug safety; Blocker

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; QUINAPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RASH; SOMNOLENCE; TASTE DISORDER; VERTIGO; VOMITING;

EID: 0029813678     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177129     Document Type: Article

References (16)

1. Sackctt DL. Haynes RB. Gent M. Taylor DW (eds): Monitoring for Drug Safety. Lancaster. MTP Press, 1980, pp 427-438.
2. Frishman WH: The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: Comparison to capto-pril. Clin Cardiol 1990:13:VII-26-VII-31.
3. Goldstein RJ: The treatment of moderate to severe hypertension with ACE inhibitors. J Cardiovasc Pharmacol 1990:15(suppl 2):S29-S35.
4. Metby JC: Quinapril, a new. effective, and well-tolerated inhibitor of angiotension converting enzyme. Adv Thcr 1990:7:175-194.
5. Jaillon P. Vicaut E. Caffe S. et al: Pharmacoepidemiology of quinapril in hypertensive patients followed for 6 months. J Cardiol Pharmacol 1992:20(suppl B):S39-S44.
6. Knapp LE, Frank GJ. McLin R. et al: The safety and tolerability of quinapril. J Cardiol Pharmacol 1990; 15(suppl 2):S47-S55.
7. Hedncr T, Thulin T. Gustafsson S. et al: A comparison of diltiazem and mctoprolol in hypertension. Swedish diltiazcm-mcloprolol mul-ticentrc study group. Eur J Clin Pharmacol 1990;39:427-433.
8. Frimodt-Mocller J, Poulson DL, Kornerup HJ, et al: Quality of life, side effects and efficacy of lisinopril compared with metoprolol in patients with mild to moderate essential hypertension. J Hum Hypertcns 1991:5:215-221.
9. La-Palio L. Schork A. Glasser S. et al: Safety and efficacy of metoprolol in the treatment of hypertension in the elderly. J Am Geriatr Soc 1992:40:354-358.
10. Costart: Modified version of the FDA-devel-oped Coding Symbols for Thesaurus of Adverse Reactions Terms. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research. Division of Epidemiology and Surveillance. Rockville. Md. 4th cd. 1994.
11. Duphuy HJ: Assessment of quality of life in clinical trials of cardiovascular therapy. Le-Jacq. 1984.
12. Croog SH, Levine S. Testa M: The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986:314:1657-1664.
13. Fletcher AE. Bulpitt CJ. Chase DM: Quality of life with three antihypertensive treatments-Cilazapril, atenolol, nifedipine. Hypertension 1992:19:499-507.
14. Beto JA, Bansal VK: Quality of life in treatment of hvpertension. J Hypertcns 1992:5: 125-133.
15. Testa MA. Anderson RB. Nackclcy JF. et al: Quality of life and antihypertensive therapy in men. J Engl J Med 1993:328:907-913.
16. Materson BJ. Reda DJ, Cushman WC, et al: Single-drug therapy for hypertension in men. N Engl J Med 1993:328:914-921.